Additionally, BKT140, inhibited primary tumor growth and metastasis of head and neck cancer, and showed a CXCR4-dependent preferential cytotoxicity towards malignant cells of hematopoietic origin in multiple myeloma [126]. Here, CXCR4 is linked to AL amyloidosis.